Poster only 3rd Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity 2022

Intervention therapy targeting the inflammatory gene, RIPK1, reduces diet-induced obesity, improves insulin sensitivity and a potential marker to predict obesity risk. (#129)

Sidney Niogret 1 , Yizhuo Wang 1 , Kritima Dhakal 1 , Sachini Fonseka 1 , Allen Feng 1 , Benjamin Weger 1 , Xichun Lee 1 , Matt Sweet 1 , Fred Gachon 1 , James Murphy 2 , Richard Lee 3 , Adam Mullick 3 , Denuja Karunakaran 1 4
  1. Institute for Molecular Bioscience, The University of Queensland , Brisbane , QLD , Australia
  2. Inflammation Division, Walter and Eliza Hall Institute of Medical Research , Melbourne , VIC , Australia
  3. Cardiovascular Drug Discovery, CIonis Pharmaceuticals, Inc, San Diego, California, USA
  4. Monash Biomedicine Discovery Institute and Victorian Heart Institute, Clatyton, VIC, Australia
Publish consent withheld